Combined use of nuclear phosphoprotein c-Myc and cellular phosphoprotein p53 for hepatocellular carcinoma detection in high-risk chronic hepatitis C patients.
CONCLUSION: c-Myc and p53 are potential HCC diagnostic biomarkers, and convenient combinations of them could improve diagnostic accuracy of HCC.
PMID: 28705056 [PubMed - as supplied by publisher]
Source: British Journal of Biomedical Science - Category: Laboratory Medicine Tags: Br J Biomed Sci Source Type: research
More News: Biomedical Science | Cancer & Oncology | Carcinoma | Genetics | Hepatitis | Hepatitis C | Hepatocellular Carcinoma | Liver | Liver Cancer | Science | UK Health | Urology & Nephrology